Dynamic Changes of the Bone Marrow Niche: Mesenchymal Stromal Cells and Their Progeny During Aging and Leukemia

Mesenchymal stromal cells (MSCs) are a heterogenous cell population found in a wide range of tissues in the body, known for their nutrient-producing and immunomodulatory functions. In the bone marrow (BM), these MSCs are critical for the regulation of hematopoietic stem cells (HSC) that are responsible for daily blood production and functional immunity throughout an entire organism’s lifespan. Alongside other stromal cells, MSCs form a specialized microenvironment BM tissue called “niche” that tightly controls HSC self-renewal and differentiation. In addition, MSCs are crucial players in maintaining bone integrity and supply of hormonal nutrients due to their capacity to differentiate into osteoblasts and adipocytes which also contribute to cellular composition of the BM niche. However, MSCs are known to encompass a large heterogenous cell population that remains elusive and poorly defined. In this review, we focus on deciphering the BM-MSC biology through recent advances in single-cell identification of hierarchical subsets with distinct functionalities and transcriptional profiles. We also discuss the contribution of MSCs and their osteo-adipo progeny in modulating the complex direct cell-to-cell or indirect soluble factors-mediated interactions of the BM HSC niche during homeostasis, aging and myeloid malignancies. Lastly, we examine the therapeutic potential of MSCs for rejuvenation and anti-tumor remedy in clinical settings.

[1]  V. Beneš,et al.  Single-cell proteo-genomic reference maps of the hematopoietic system enable the purification and massive profiling of precisely defined cell states , 2021, Nature Immunology.

[2]  J. Dick,et al.  "Human, mouse and dog bone marrow show similar mesenchymal stromal cells within a distinctive microenvironment". , 2021, Experimental hematology.

[3]  S. Cairo,et al.  Targeting mesenchymal stromal cells plasticity to reroute acute myeloid leukemia course. , 2021, Blood.

[4]  E. Morii,et al.  Identification of CXCL12‐abundant reticular cells in human adult bone marrow , 2021, British journal of haematology.

[5]  Xiaoxiao Zhou,et al.  CircRNA hsa_circ_0006215 promotes osteogenic differentiation of BMSCs and enhances osteogenesis–angiogenesis coupling by competitively binding to miR-942-5p and regulating RUNX2 and VEGF , 2021, Aging.

[6]  Jiong Cai,et al.  Non-Coding RNAs Steering the Senescence-Related Progress, Properties, and Application of Mesenchymal Stem Cells , 2021, Frontiers in Cell and Developmental Biology.

[7]  R. Harman,et al.  Translational Animal Models Provide Insight Into Mesenchymal Stromal Cell (MSC) Secretome Therapy , 2021, Frontiers in Cell and Developmental Biology.

[8]  Jiao Li,et al.  The elevated level of IL-1α in the bone marrow of aged mice leads to MSC senescence partly by down-regulating Bmi-1 , 2021, Experimental Gerontology.

[9]  I. Dolgalev,et al.  Connecting the Dots: Resolving the Bone Marrow Niche Heterogeneity , 2021, Frontiers in Cell and Developmental Biology.

[10]  W. Shi,et al.  RhoA/Rock activation represents a new mechanism for inactivating Wnt/β-catenin signaling in the aging-associated bone loss , 2021, Cell Regeneration.

[11]  T. Schroeder,et al.  Symmetric and asymmetric activation of hematopoietic stem cells , 2021, Current opinion in hematology.

[12]  K. Lyons,et al.  Loss of KDM4B exacerbates bone-fat imbalance and mesenchymal stromal cell exhaustion in skeletal aging. , 2021, Cell stem cell.

[13]  M. Shimaoka,et al.  Remodeling of Bone Marrow Niches and Roles of Exosomes in Leukemia , 2021, International journal of molecular sciences.

[14]  Pengfei Qin,et al.  Integrated decoding hematopoiesis and leukemogenesis using single-cell sequencing and its medical implication , 2021, Cell discovery.

[15]  G. Mufti,et al.  Ectopic humanized mesenchymal niche in mice enables robust engraftment of myelodysplastic stem cells. , 2020, Blood cancer discovery.

[16]  Jeronimo Conceição Ruiz,et al.  Microfluidics and organ-on-a-chip technologies: A systematic review of the methods used to mimic bone marrow , 2020, PloS one.

[17]  P. Boor,et al.  Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis , 2020, Cell stem cell.

[18]  Ying-ai Shi,et al.  Sirt3 Attenuates Oxidative Stress Damage and Rescues Cellular Senescence in Rat Bone Marrow Mesenchymal Stem Cells by Targeting Superoxide Dismutase 2 , 2020, Frontiers in Cell and Developmental Biology.

[19]  Katayoun Farrahi,et al.  Transfer learning efficiently maps bone marrow cell types from mouse to human using single-cell RNA sequencing , 2020, Communications Biology.

[20]  K. Xia,et al.  Autophagy receptor OPTN (optineurin) regulates mesenchymal stem cell fate and bone-fat balance during aging by clearing FABP3 , 2020, Autophagy.

[21]  F. Karadeniz,et al.  Effect of Quercetin 3-O-β-D-Galactopyranoside on the Adipogenic and Osteoblastogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stromal Cells , 2020, International journal of molecular sciences.

[22]  M. Boldin,et al.  microRNA‐146a controls age‐related bone loss , 2020, Aging cell.

[23]  Xiaoting Liang,et al.  Senescent mesenchymal stem/stromal cells and restoring their cellular functions , 2020, World journal of stem cells.

[24]  Y. Fujiwara,et al.  Osteocyte RANKL is required for cortical bone loss with age and is induced by senescence , 2020, JCI insight.

[25]  L. Liggett,et al.  Unraveling Hematopoiesis through the Lens of Genomics , 2020, Cell.

[26]  C. Nerlov,et al.  Micro-environmental sensing by bone marrow stroma identifies IL-6 and TGFβ1 as regulators of hematopoietic ageing , 2020, Nature Communications.

[27]  Xiaolong Liu,et al.  Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress , 2020, Stem Cell Research & Therapy.

[28]  Li Li,et al.  Celastrol regulates bone marrow mesenchymal stem cell fate and bone-fat balance in osteoporosis and skeletal aging by inducing PGC-1α signaling , 2020, Aging.

[29]  F. Vizoso,et al.  Functional heterogeneity of mesenchymal stem cells from natural niches to culture conditions: implications for further clinical uses , 2020, Cellular and Molecular Life Sciences.

[30]  B. Bisikirska,et al.  Lipocalin-2 counteracts metabolic dysregulation in obesity and diabetes , 2020, The Journal of experimental medicine.

[31]  J. Karp,et al.  Shattering barriers toward clinically meaningful MSC therapies , 2020, Science Advances.

[32]  O. Ornatsky,et al.  Human Aging Alters the Spatial Organization between CD34+ Hematopoietic Cells and Adipocytes in Bone Marrow , 2020, Stem cell reports.

[33]  Mingyao Li,et al.  Single cell transcriptomics identifies a unique adipose lineage cell population that regulates bone marrow environment , 2020, eLife.

[34]  M. Schiller,et al.  Single-cell RNA sequencing deconvolutes the in vivo heterogeneity of human bone marrow-derived mesenchymal stem cells , 2020, bioRxiv.

[35]  Yan Zhang,et al.  Indian Hedgehog regulates senescence in bone marrow-derived mesenchymal stem cell through modulation of ROS/mTOR/4EBP1, p70S6K1/2 pathway , 2020, Aging.

[36]  Byung-Kyu Suh,et al.  Bone morbidity in pediatric acute lymphoblastic leukemia , 2020, Annals of pediatric endocrinology & metabolism.

[37]  J. Gribben,et al.  Bone marrow niches in haematological malignancies , 2020, Nature Reviews Cancer.

[38]  Z. Estrov,et al.  A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia , 2020, Leukemia.

[39]  J. Ankrum,et al.  Editorial: Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies , 2020, Frontiers in Immunology.

[40]  A. Martín-Montalvo,et al.  Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy , 2020, Frontiers in Bioengineering and Biotechnology.

[41]  D. Vetrie,et al.  The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML , 2020, Nature Reviews Cancer.

[42]  S. Kousteni,et al.  Mapping and targeting of the leukemic microenvironment , 2019, The Journal of experimental medicine.

[43]  B. Ebert,et al.  Clonal Hematopoiesis as a Model for Premalignant Changes During Aging. , 2019, Experimental hematology.

[44]  T. Schinke,et al.  Chemokines in Physiological and Pathological Bone Remodeling , 2019, Front. Immunol..

[45]  M. Longaker,et al.  A Revised Perspective of Skeletal Stem Cell Biology , 2019, Front. Cell Dev. Biol..

[46]  C. López-Otín,et al.  Remodeling of Bone Marrow Hematopoietic Stem Cell Niches Promotes Myeloid Cell Expansion during Premature or Physiological Aging , 2019, Cell stem cell.

[47]  R. Farahzadi,et al.  Mesenchymal stem cells in acute myeloid leukemia: a focus on mechanisms involved and therapeutic concepts , 2019, Blood research.

[48]  Patrick M. Helbling,et al.  Global transcriptomic profiling of the bone marrow stromal microenvironment during postnatal development, aging and inflammation , 2019, bioRxiv.

[49]  A. Iwama,et al.  Bmi1 restricts the adipogenic differentiation of bone marrow stromal cells to maintain the integrity of the hematopoietic stem cell niche. , 2019, Experimental hematology.

[50]  Patrick M. Helbling,et al.  Combined single-cell and spatial transcriptomics reveals the molecular, cellular and spatial bone marrow niche organization , 2019, Nature Cell Biology.

[51]  Anjali P. Kusumbe,et al.  Angiocrine signals regulate quiescence and therapy resistance in bone metastasis , 2019, JCI insight.

[52]  M. Le Bousse-Kerdilès,et al.  Mesenchymal stromal cells confer chemoresistance to myeloid leukemia blasts through Side Population functionality and ABC transporter activation , 2019, Haematologica.

[53]  Frédérick A. Mallette,et al.  mTOR as a central regulator of lifespan and aging , 2019, F1000Research.

[54]  Samuel L. Wolock,et al.  Mapping Distinct Bone Marrow Niche Populations and Their Differentiation Paths. , 2019, Cell reports.

[55]  Monika S. Kowalczyk,et al.  A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia , 2019, Cell.

[56]  D. Hedley,et al.  Mobilization of Leukemic Cells Using Plerixafor as Part of a Myeloablative Preparative Regimen for Patients with Acute Myelogenous Leukemia Undergoing Allografting: Assessment of Safety and Tolerability. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[57]  H. Ouyang,et al.  Single-Cell Profiles and Clinically Useful Properties of Human Mesenchymal Stem Cells of Adipose and Bone Marrow Origin , 2019, The American journal of sports medicine.

[58]  Michael R. Elliott,et al.  Aged marrow macrophages expand platelet-biased hematopoietic stem cells via Interleukin1B. , 2019, JCI insight.

[59]  Xiaoting Liang,et al.  FGF21 Mediates Mesenchymal Stem Cell Senescence via Regulation of Mitochondrial Dynamics , 2019, Oxidative medicine and cellular longevity.

[60]  R. Satija,et al.  The bone marrow microenvironment at single-cell resolution , 2019, Nature.

[61]  Avi Ma’ayan,et al.  Engineering a haematopoietic stem cell niche by revitalizing mesenchymal stromal cells , 2019, Nature Cell Biology.

[62]  P. Frenette,et al.  Haematopoietic stem cell activity and interactions with the niche , 2019, Nature Reviews Molecular Cell Biology.

[63]  A. Barrett,et al.  Human Wharton's Jelly Mesenchymal Stem Cells Show Unique Gene Expression Compared with Bone Marrow Mesenchymal Stem Cells Using Single-Cell RNA-Sequencing. , 2019, Stem cells and development.

[64]  H. Koo,et al.  Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges , 2019, Leukemia.

[65]  B. Ebert,et al.  Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome , 2019, Leukemia.

[66]  Yingdong Zhao,et al.  Single cell sequencing reveals gene expression signatures associated with bone marrow stromal cell subpopulations and time in culture , 2019, Journal of Translational Medicine.

[67]  Mi Yang,et al.  Long noncoding RNA Bmncr regulates mesenchymal stem cell fate during skeletal aging , 2018, The Journal of clinical investigation.

[68]  J. Jing,et al.  BMP-IHH-mediated interplay between mesenchymal stem cells and osteoclasts supports calvarial bone homeostasis and repair , 2018, Bone Research.

[69]  C. Piccinato,et al.  Individual response to mTOR inhibition in delaying replicative senescence of mesenchymal stromal cells , 2018, bioRxiv.

[70]  Marc N. Wein,et al.  Regulation of Bone Remodeling by Parathyroid Hormone. , 2018, Cold Spring Harbor perspectives in medicine.

[71]  L. Mei,et al.  YAP promotes osteogenesis and suppresses adipogenic differentiation by regulating β-catenin signaling , 2018, Bone Research.

[72]  U. Platzbecker,et al.  Associations of myeloid hematological diseases of the elderly with osteoporosis: A longitudinal analysis of routine health care data. , 2018, Leukemia research.

[73]  J. Scandura,et al.  Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia , 2018, Haematologica.

[74]  M. Schäfers,et al.  Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation , 2018, The Journal of clinical investigation.

[75]  P. Frenette,et al.  Niches for Hematopoietic Stem Cells and Their Progeny. , 2018, Immunity.

[76]  Albert A. Rizvanov,et al.  Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment , 2018, Front. Pharmacol..

[77]  A. Zimran,et al.  Bone loss and hematological malignancies in adults: a pilot study , 2018, Supportive Care in Cancer.

[78]  P. Frenette,et al.  Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche , 2018, Nature Medicine.

[79]  M. Carroll,et al.  Dexamethasone in hyperleukocytic acute myeloid leukemia , 2018, Haematologica.

[80]  T. Barbui,et al.  The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion , 2018, Blood Cancer Journal.

[81]  Catriona McLean,et al.  Inhibition of Endosteal Vascular Niche Remodeling Rescues Hematopoietic Stem Cell Loss in AML , 2018, Cell stem cell.

[82]  O. Ilhan,et al.  DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia. , 2017, Leukemia research.

[83]  R. Cancedda,et al.  LCN2 overexpression in bone enhances the hematopoietic compartment via modulation of the bone marrow microenvironment , 2017, Journal of cellular physiology.

[84]  Michael G. Kharas,et al.  Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation. , 2017, Cancer research.

[85]  S. Soneji,et al.  Human Primary Bone Marrow Mesenchymal Stromal Cells and Their in vitro Progenies Display Distinct Transcriptional Profile Signatures , 2017, Scientific Reports.

[86]  Hartmut Geiger,et al.  HSC Niche Biology and HSC Expansion Ex Vivo. , 2017, Trends in molecular medicine.

[87]  E. Hsiao,et al.  Sirtuin‐3 Promotes Adipogenesis, Osteoclastogenesis, and Bone Loss in Aging Male Mice , 2017, Endocrinology.

[88]  C. Chen,et al.  Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion , 2017, Leukemia.

[89]  Jennifer M. Miller,et al.  Interleukin-6 levels predict event-free survival in pediatric AML and suggest a mechanism of chemotherapy resistance. , 2017, Blood advances.

[90]  Je-Yoel Cho,et al.  Fibroblast growth factor 2 supports osteoblastic niche cells during hematopoietic homeostasis recovery after bone marrow suppression , 2017, Cell Communication and Signaling.

[91]  L. Calvi,et al.  The Notch Ligand Jagged1 Regulates the Osteoblastic Lineage by Maintaining the Osteoprogenitor Pool , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[92]  M. L. Le Beau,et al.  Inhibition of WNT signaling in the bone marrow niche prevents the development of MDS in the Apcdel/+ MDS mouse model. , 2017, Blood.

[93]  Victor G. Puelles,et al.  Gli1+ Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target. , 2017, Cell stem cell.

[94]  R. Baron,et al.  Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate. , 2017, Cell metabolism.

[95]  C. Rosen,et al.  Bone-Fat Interaction. , 2017, Endocrinology and metabolism clinics of North America.

[96]  J. Gribben,et al.  Versatile humanized niche model enables study of normal and malignant human hematopoiesis , 2017, The Journal of clinical investigation.

[97]  S. Goodman,et al.  Decreased osteogenesis in mesenchymal stem cells derived from the aged mouse is associated with enhanced NF‐κB activity , 2017, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[98]  Yulin Li,et al.  Nampt Expression Decreases Age-Related Senescence in Rat Bone Marrow Mesenchymal Stem Cells by Targeting Sirt1 , 2017, PloS one.

[99]  G. Blunn,et al.  Parathyroid hormone 1-34 and skeletal anabolic action , 2017, Bone & joint research.

[100]  E. Scott,et al.  Extended time-lapse in vivo imaging of tibia bone marrow to visualize dynamic hematopoietic stem cell engraftment , 2016, Leukemia.

[101]  B. Ebert,et al.  The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia , 2016, Nature Reviews Cancer.

[102]  R. Kanaar,et al.  Mesenchymal Inflammation Drives Genotoxic Stress in Hematopoietic Stem Cells and Predicts Disease Evolution in Human Pre-leukemia. , 2016, Cell stem cell.

[103]  D. Scadden,et al.  Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment , 2016, Nature.

[104]  Yongchang Chen,et al.  Exosomes derived from human mesenchymal stem cells promote gastric cancer cell growth and migration via the activation of the Akt pathway. , 2016, Molecular medicine reports.

[105]  R. Oster,et al.  Enhanced Hematopoietic Stem Cell Self‐Renewal‐Promoting Ability of Clonal Primary Mesenchymal Stromal/Stem cells Versus Their Osteogenic Progeny , 2016, Stem cells.

[106]  D. Scadden,et al.  Distinctive Mesenchymal-Parenchymal Cell Pairings Govern B Cell Differentiation in the Bone Marrow , 2016, Stem cell reports.

[107]  O. MacDougald,et al.  Marrow Adipose Tissue: Trimming the Fat , 2016, Trends in Endocrinology & Metabolism.

[108]  Mario Cazzola,et al.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.

[109]  Ron-Patrick Cadeddu,et al.  Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia , 2016, Leukemia.

[110]  X Zhang,et al.  Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? , 2016, Cell Death and Differentiation.

[111]  Z. Gu,et al.  Mesenchymal stem cell-derived exosomes facilitate nasopharyngeal carcinoma progression. , 2016, American journal of cancer research.

[112]  Charles P. Lin,et al.  Distinct Bone Marrow Blood Vessels Differentially Regulate Normal and Malignant Hematopoietic Stem and Progenitor Cells , 2015 .

[113]  Fengyun Zhang,et al.  Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells , 2015, Stem Cell Research & Therapy.

[114]  S. Leem,et al.  Microenvironmental remodeling as a parameter and prognostic factor of heterogeneous leukemogenesis in acute myelogenous leukemia. , 2015, Cancer research.

[115]  P. Bianco,et al.  Skeletal stem cells , 2015, Development.

[116]  Andrew F. Hill,et al.  Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper , 2015, Journal of extracellular vesicles.

[117]  C. Brochhausen-Delius,et al.  Prostaglandin E2 , 2014, Der Pathologe.

[118]  R. Yadak,et al.  SMAD Signaling Regulates CXCL12 Expression in the Bone Marrow Niche, Affecting Homing and Mobilization of Hematopoietic Progenitors , 2014, Stem cells.

[119]  S. Armstrong,et al.  Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche. , 2014, Cell stem cell.

[120]  H. Okano,et al.  Leptin receptor makes its mark on MSCs. , 2014, Cell stem cell.

[121]  Y. Hayashi,et al.  Parathyroid Hormone Enhances Hematopoietic Expansion Via Upregulation of Cadherin‐11 in Bone Marrow Mesenchymal Stromal Cells , 2014, Stem cells.

[122]  D. Lai,et al.  Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms , 2014, Nature.

[123]  T. Enver,et al.  Leukemia propagating cells rebuild an evolving niche in response to therapy. , 2014, Cancer cell.

[124]  D. Bernlohr,et al.  Lipocalin 2 Regulates Brown Fat Activation via a Nonadrenergic Activation Mechanism* , 2014, The Journal of Biological Chemistry.

[125]  A. Trumpp,et al.  Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit. , 2014, Cell stem cell.

[126]  R. Adams,et al.  Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone , 2014, Nature.

[127]  A. Jahanian-Najafabadi,et al.  Lipocalin 2 decreases senescence of bone marrow-derived mesenchymal stem cells under sub-lethal doses of oxidative stress , 2014, Cell Stress and Chaperones.

[128]  R. Rabadán,et al.  Leukemogenesis Induced by an Activating β-catenin mutation in Osteoblasts , 2014, Nature.

[129]  C. Paton,et al.  Lipocalin‐2 increases fat oxidation in vitro and is correlated with energy expenditure in normal weight but not obese women , 2013, Obesity.

[130]  A. Bergman,et al.  Arteriolar niches maintain haematopoietic stem cell quiescence , 2013, Nature.

[131]  T. Olson,et al.  IGF‐1‐mediated osteoblastic niche expansion enhances long‐term hematopoietic stem cell engraftment after murine bone marrow transplantation , 2013, Stem cells.

[132]  Greg Maguire,et al.  Stem cell therapy without the cells , 2013, Communicative & integrative biology.

[133]  E. Hsiao,et al.  Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. , 2013, Cell stem cell.

[134]  I. Bruns,et al.  Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells , 2013, Leukemia.

[135]  C. Di Cresce,et al.  Regional localization within the bone marrow influences the functional capacity of human HSCs. , 2013, Cell stem cell.

[136]  I. Bruns,et al.  PDGFRα and CD51 mark human Nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion , 2013, The Journal of experimental medicine.

[137]  R. Zhao,et al.  Exosomes from human adipose-derived mesenchymal stem cells promote migration through Wnt signaling pathway in a breast cancer cell model , 2013, Molecular and Cellular Biochemistry.

[138]  H. Northoff,et al.  Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells , 2013, BMC Medicine.

[139]  A. Jahanian-Najafabadi,et al.  Lipocalin-2-mediated upregulation of various antioxidants and growth factors protects bone marrow-derived mesenchymal stem cells against unfavorable microenvironments , 2013, Cell Stress and Chaperones.

[140]  S. Rafii,et al.  TGFβ restores hematopoietic homeostasis after myelosuppressive chemotherapy , 2013, The Journal of experimental medicine.

[141]  Lev Silberstein,et al.  Differential Stem and Progenitor Cell Trafficking by Prostaglandin E2 , 2013, Nature.

[142]  R. Baron,et al.  Myelopoiesis is regulated by osteocytes through Gsα-dependent signaling. , 2013, Blood.

[143]  S. Morrison,et al.  Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches , 2013, Nature.

[144]  A. Korman,et al.  BMS-936564/MDX-1338: A Fully Human Anti-CXCR4 Antibody Induces Apoptosis In Vitro and Shows Antitumor Activity In Vivo in Hematologic Malignancies , 2012, Clinical Cancer Research.

[145]  L. Calvi,et al.  PTH expands short-term murine hemopoietic stem cells through T cells. , 2012, Blood.

[146]  P. Opolon,et al.  CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model , 2012, Cell Death and Disease.

[147]  L. Xian,et al.  Parathyroid hormone induces differentiation of mesenchymal stromal/stem cells by enhancing bone morphogenetic protein signaling , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[148]  Marcos González,et al.  Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients , 2012, Haematologica.

[149]  Je-Yoel Cho,et al.  Differential regulation of CXCL5 by FGF2 in osteoblastic and endothelial niche cells supports hematopoietic stem cell migration. , 2012, Stem cells and development.

[150]  F. Jakob,et al.  Indian hedgehog gene transfer is a chondrogenic inducer of human mesenchymal stem cells , 2012, Arthritis Research & Therapy.

[151]  P. Madeddu,et al.  Bone marrow microenvironment: a newly recognized target for diabetes-induced cellular damage. , 2012, Endocrine, metabolic & immune disorders drug targets.

[152]  L. Calvi,et al.  Osteoblastic expansion induced by parathyroid hormone receptor signaling in murine osteocytes is not sufficient to increase hematopoietic stem cells. , 2012, Blood.

[153]  Lei Ding,et al.  Endothelial and perivascular cells maintain haematopoietic stem cells , 2011, Nature.

[154]  K. Tian,et al.  p38 MAPK Contributes to the Growth Inhibition of Leukemic Tumor Cells Mediated by Human Umbilical Cord Mesenchymal Stem Cells , 2011, Cellular Physiology and Biochemistry.

[155]  Ben D. MacArthur,et al.  Mesenchymal and haematopoietic stem cells form a unique bone marrow niche , 2010, Nature.

[156]  K. Lyons,et al.  Wnt10b Deficiency Results in Age-Dependent Loss of Bone Mass and Progressive Reduction of Mesenchymal Progenitor Cells , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[157]  Wendy S. Wright,et al.  Lipocalin-2 Deficiency Impairs Thermogenesis and Potentiates Diet-Induced Insulin Resistance in Mice , 2010, Diabetes.

[158]  Charles P. Lin,et al.  Bone progenitor dysfunction induces myelodysplasia and secondary leukemia , 2010, Nature.

[159]  A. Rustgi,et al.  Identification of a bone marrow-derived mesenchymal progenitor cell subset that can contribute to the gastric epithelium , 2009, Laboratory Investigation.

[160]  A. S. Bailey,et al.  BMP4 regulates the hematopoietic stem cell niche. , 2009, Blood.

[161]  R. O’Keefe,et al.  In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells. , 2009, Blood.

[162]  A. Miyawaki,et al.  Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow , 2009, The Journal of experimental medicine.

[163]  A. C. Yazici,et al.  Human bone marrow mesenchymal cells express NG2: possible increase in discriminative ability of flow cytometry during mesenchymal stromal cell identification. , 2009, Cytotherapy.

[164]  Gang Li,et al.  Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis. , 2009, Cancer letters.

[165]  J. Sampath,et al.  Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. , 2009, Blood.

[166]  A. Kate Sasser,et al.  Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression , 2009, PloS one.

[167]  A. McMahon,et al.  Osteoblastic regulation of B lymphopoiesis is mediated by Gsα-dependent signaling pathways , 2008, Proceedings of the National Academy of Sciences.

[168]  Y. Shiozawa,et al.  Hematopoietic Stem Cells Regulate Mesenchymal Stromal Cell Induction into Osteoblasts Thereby Participating in the Formation of the Stem Cell Niche , 2008, Stem cells.

[169]  Yukio Nakamura,et al.  Lipocalin 2‐mediated growth suppression is evident in human erythroid and monocyte/macrophage lineage cells , 2008, Journal of cellular physiology.

[170]  Zhe Wang,et al.  Effects of human bone marrow stromal cell line (HFCL) on the proliferation, differentiation and apoptosis of acute myeloid leukemia cell lines U937, HL-60 and HL-60/VCR , 2008, International journal of hematology.

[171]  T. Suda,et al.  Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. , 2007, Cell stem cell.

[172]  Lina A. Thoren,et al.  Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. , 2007, Cell stem cell.

[173]  Satoshi Tanaka,et al.  Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region , 2007, Nature Biotechnology.

[174]  B. Sacchetti,et al.  Self-Renewing Osteoprogenitors in Bone Marrow Sinusoids Can Organize a Hematopoietic Microenvironment , 2007, Cell.

[175]  D. Banerjee,et al.  The therapeutic potential of mesenchymal stem cells , 2007, Expert opinion on biological therapy.

[176]  D. Scadden,et al.  Therapeutic targeting of a stem cell niche , 2007, Nature Biotechnology.

[177]  L. Calvi,et al.  The interplay of osteogenesis and hematopoiesis , 2004, The Journal of cell biology.

[178]  Keisuke Ito,et al.  Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche , 2004, Cell.

[179]  T. Jensen,et al.  Regulation of Human Skeletal Stem Cells Differentiation by Dlk1/Pref‐1 , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[180]  D. Scadden,et al.  Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.

[181]  Haiyang Huang,et al.  Identification of the haematopoietic stem cell niche and control of the niche size , 2003, Nature.

[182]  F. Appelbaum,et al.  Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5). , 2001, Experimental hematology.

[183]  R. Baron,et al.  Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. , 2001, The Journal of clinical investigation.

[184]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[185]  A. Cryer,et al.  The differentiation of a potential mesenchymal stem cell population within ovine bone marrow. , 1994, Biochemical Society transactions.

[186]  U. Trechsel [The regulation of bone remodeling]. , 1986, Schweizerische medizinische Wochenschrift.

[187]  D. Goltzman The Aging Skeleton. , 2019, Advances in experimental medicine and biology.

[188]  J. Esteve,et al.  A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia , 2018, Annals of Hematology.

[189]  David W. Rowe,et al.  Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche , 2009, Nature.

[190]  Winfried Wiegraebe,et al.  Detection of functional haematopoietic stem cell niche using real-time imaging , 2009, Nature.

[191]  J. Sampath,et al.  Prostaglandin E 2 enhances hematopoietic stem cell homing , survival , and proliferation , 2009 .

[192]  R. O’Keefe,et al.  In vivo prostaglandin E 2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells , 2009 .

[193]  杉山 立樹 Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches , 2007 .

[194]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[195]  I. Wilmut Differentiation potential. , 1999, Cloning.

[196]  J. David Macrophage migration. , 1968, Federation proceedings.

[197]  P. Boccuni,et al.  Transforming growth factor (cid:1) -induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation , 2004 .